Cargando…

Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways

There is an urgent clinical need for targeted therapy approaches for triple-negative breast cancer (TNBC) patients. Increasing evidences suggested that the expression of estrogen-related receptor alpha (ERRα) was correlate with unfavorable clinical outcomes of breast cancer patients. We here show th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ying-Min, Chen, Zhuo-Jia, Jiang, Guan-Min, Zhang, Kun-Shui, Liu, Qiao, Liang, Shu-Wei, Zhou, Yan, Huang, Hong-Bin, Du, Jun, Wang, Hong-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914305/ https://www.ncbi.nlm.nih.gov/pubmed/26871469 http://dx.doi.org/10.18632/oncotarget.7276

Ejemplares similares

Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin
por: Wu, Ying-Min, et al.
Publicado: (2015)

The Estrogen-Related Receptor α Inverse Agonist XCT 790 Is a Nanomolar Mitochondrial Uncoupler
por: Eskiocak, Banu, et al.
Publicado: (2014)

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro
por: Schüler-Toprak, Susanne, et al.
Publicado: (2016)

Estrogen receptor α in T cells suppresses follicular helper T cell responses and prevents autoimmunity
por: Kim, Do-Hyun, et al.
Publicado: (2019)

The discovery of a novel series of potential ERRα inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer in vivo
por: Gao, Zhipei, et al.
Publicado: (2021)

Propofol induces ROS-mediated intrinsic apoptosis and migration in triple-negative breast cancer cells
por: Wang, Hao, et al.
Publicado: (2020)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
por: Lee, Sang Min, et al.
Publicado: (2015)

Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha
por: Karnati, Konda Reddy, et al.
Publicado: (2020)

Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α
por: Rossini, Elisa, et al.
Publicado: (2021)

RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers
por: Pang, Kyoungwha, et al.
Publicado: (2019)

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
por: Zhou, Yan, et al.
Publicado: (2016)

Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists
por: Ng, Hui Wen, et al.
Publicado: (2014)

Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer
por: Ye, Shuang, et al.
Publicado: (2020)

Identification of Selective ERRγ Inverse Agonists
por: Kim, Jina, et al.
Publicado: (2016)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

Estrogen receptor variant ER‐α36 promotes tamoxifen agonist activity in glioblastoma cells
por: Qu, Chao, et al.
Publicado: (2019)

The Interaction between Macrophages and Triple‐negative Breast Cancer Cells Induces ROS‐Mediated Interleukin 1α Expression to Enhance Tumorigenesis and Metastasis
por: Hao, Meng, et al.
Publicado: (2023)

Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer
por: Hollmén, Maija, et al.
Publicado: (2015)

Tetraarsenic hexoxide enhances generation of mitochondrial ROS to promote pyroptosis by inducing the activation of caspase-3/GSDME in triple-negative breast cancer cells
por: An, Haein, et al.
Publicado: (2021)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer
por: Xu, Junnan, et al.
Publicado: (2018)

Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells
por: Gupta, Nehal, et al.
Publicado: (2021)

Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation
por: Zhang, Xiyu, et al.
Publicado: (2015)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Location of Triple-Negative Breast Cancers: Comparison with Estrogen Receptor-Positive Breast Cancers on MR Imaging
por: Kim, Won Hwa, et al.
Publicado: (2015)

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α
por: Bialesova, Lucia, et al.
Publicado: (2017)

Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
por: Ramadan, Wafaa S, et al.
Publicado: (2018)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)

Modulation of Autophagy by a Small Molecule Inverse Agonist of ERRα Is Neuroprotective
por: Suresh, S. N., et al.
Publicado: (2018)

Targeting Triple-Negative Breast Cancer by the Phytopolyphenol Carnosol: ROS-Dependent Mechanisms
por: Alsamri, Halima, et al.
Publicado: (2023)

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer
por: Li, Xintong, et al.
Publicado: (2022)

Enhanced mitochondrial fission inhibits triple-negative breast cancer cell migration through an ROS-dependent mechanism
por: Humphries, Brock A., et al.
Publicado: (2023)

Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2023)

Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
por: Wu, Guangzhen, et al.
Publicado: (2019)

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na(+)/I(−) Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells
por: Singh, Thoudam Debraj, et al.
Publicado: (2023)

Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
por: Adhikary, T, et al.
Publicado: (2013)

Osthole inhibits triple negative breast cancer cells by suppressing STAT3
por: Dai, Xuanxuan, et al.
Publicado: (2018)

Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
por: Mao, XiaoDan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_91e35o3na2bu5dnmf53j0fjfpd